The National Center for HIV, STD and TB Prevention of the Centers for Disease Control and Prevention (CDC) Announces the Following External Consultant Meeting

---
identifier: "/us/fr/01-5504"
source: "fr"
legal_status: "authoritative_unofficial"
title: "The National Center for HIV, STD and TB Prevention of the Centers for Disease Control and Prevention (CDC) Announces the Following External Consultant Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "01-5504"
section_name: "The National Center for HIV, STD and TB Prevention of the Centers for Disease Control and Prevention (CDC) Announces the Following External Consultant Meeting"
positive_law: false
currency: "2001-03-07"
last_updated: "2001-03-07"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "01-5504"
document_type: "notice"
publication_date: "2001-03-07"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "66 FR 13745"
fr_volume: 66
---


#  The National Center for HIV, STD and TB Prevention of the Centers for Disease Control and Prevention (CDC) Announces the Following External Consultant Meeting

*Name:* External Consultant Meeting on Nonoccupational Antiretroviral Postexposure Prophylaxis (nPEP).

*Times and Dates:* 8 a.m.-5 p.m., May 10, 2001. 8:30 a.m.-3:15 p.m., May 11, 2001.

*Place:* Atlanta Hilton and Towers-Downtown, 255 Courtland Street, NE, Atlanta, GA 30303.

*Status:* Open to the public, limited only by the space available.

*Purpose:* Attendees at this meeting will discuss and make recommendations *as individuals * to the Division of HIV/AIDS Prevention-Surveillance and Epidemiology on matters related to the potential use of antiretroviral medications and other interventions following sexual, injection drug use, and other non-occupational exposures to human immunodeficiency virus with a resulting risk of infection.

*Matters To Be Discussed:* Agenda items will include: a review of data on the potential efficacy of antiretroviral prophylaxis in occupational, perinatal, and non-human primate retroviral exposures; information on the extent of, and situations leading to requests for, and provision of, nPEP in the United States; whether and how additional data to determine nPEP efficacy in humans can be collected; and whether and how the CDC and the Public Health Service should amend its 1998 statement on nPEP considerations.

*Contact Person for More Information:* Dr. Dawn K. Smith, Medical Epidemiologist, NCHSTP, CDC, 1600 Clifton Road, NE, M/S E-45, Atlanta, Georgia 30333, telephone 404-639-6165. The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: March 1, 2001.

Carolyn J. Russell,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.